Transient emergence of hepatitis B variants in a patient with chronic hepatitis B resistant to lamivudine

Journal of Hepatology

Volumn 28, Issue 3, 1998, Pages 510-513

  Buti, Maria ^a   Jardi, Rosendo ^a   Cotrina, Montserrat ^a   Rodriguez Frias, Francisco ^a   Esteban, Rafael ^a   Guardia, Jaime ^a  

^a HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

Author keywords

Chronic hepatitis B; Lamivudine; Mutations

Indexed keywords

ALANINE AMINOTRANSFERASE; LAMIVUDINE; LEUCINE; METHIONINE; PYRIMIDINE NUCLEOTIDE; TYROSINE; VALINE; VIRUS DNA;

ADULT; AMINO ACID SUBSTITUTION; ARTICLE; CASE REPORT; DRUG WITHDRAWAL; GENE MUTATION; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; HUMAN TISSUE; LIVER TRANSPLANTATION; MALE; PRIORITY JOURNAL; VIRUS GENE; VIRUS REPLICATION; VIRUS RESISTANCE; VIRUS STRAIN; VIRUS TRANSMISSION;

EID: 0032032948     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(98)80327-9     Document Type: Article

References (11)

1. Schalm SW, Deman RA, Heitjink RA, Niesters HGM. New nucleoside analogues for chronic hepatitis B. J Hepatol. 22:1995;52-56.
2. Dienstag JL, Perrillo RP, Schiff ER, Bartholomew M, Vicary C, Rubin M. A preliminary trial of lamivudine for chronic hepatitis B infection. N Engl J Med. 333:1995;1657-1661.
3. Lai C-L, Ching C-H, Tung AK, Li E, Young J, Hill A, et al. Lamivudine is effective in suppressing hepatitis B virus DNA in Chinese hepatitis B surface antigen carriers: a placebo-controlled trial. Hepatology. 25:1997;241-244.
4. Ling R, Mutimer D, Ahmed M, Boxall E, Elias E, Dusheiko G, et al. Selection of mutations in the hepatitis B virus polymerase during therapy of transplanted recipients with lamivudine. Hepatology. 24:1996;711-713.
5. Bartholomew M, Jansen RW, Lennox JJ, Reddy RR, Johnson LC, Bunzendahi H, et al. Hepatitis B-virus resistance to lamivudine given for recurrent infection after orthotopic liver transplantation. Lancet. 349:1997;20-22.
6. Tipples GA, Ma MM, Fischer KP, Bain VG, Kneteman NM, Tyrell DL. Mutation in HBV RNA-dependent DNA polymerase confers resistance to lamivudine in vivo. Hepatology. 24:1996;714-717.
7. Dienstag JL, Schiff ER, Mitchell M, Gitlin N, Lissoos T, Condreay L, et al. Extended lamivudine re-treatment for chronic hepatitis B. Hepatology. 24:1996;245.
8. Perillo R, Rakela J, Martin P, Levy G, Schiff E, Wright T, et al. Lamivudine for hepatitis B after liver transplantation. Hepatology. 24:1996;223.
9. Grellier L, Mutimer D, Ahmed M, Brown D, Burroughs AK, Rolles K, et al. Lamivudine prophylaxis against reinfection in liver transplantation for hepatitis B cirrhosis. Lancet. 348:1996;1212-1215.
10. Honkoop P, Man RA, Heitjenk RA, Schalm SW. Hepatitis B reactivation after lamivudine. Lancet. 346:1995;1156-1157.
11. Schalm S. Clinical implications of lamivudine resistance by HBV. Lancet. 349:1997;3-4.